Get the Stockscreener App
1.45
6.45%
-0.10
Pre-market:
1.45
Catheter Precision Inc. stock is traded at $1.45, with a volume of 13,263.
It is down -6.45% in the last 24 hours and down -22.46% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$1.55
Open:
$1.49
24h Volume:
13,263
Relative Volume:
0.17
Market Cap:
$2.52M
Revenue:
$24,000
Net Income/Loss:
$-78.06M
P/E Ratio:
-0.05
EPS:
-28.9956
Net Cash Flow:
$-21.81M
1W Performance:
-11.04%
1M Performance:
-22.46%
6M Performance:
-42.91%
1Y Performance:
-77.13%
1-Day Range:
$1.4401
$1.51
1-Week Range:
$1.43
$1.66
52-Week Range:
$1.14
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
1.45 | 2.70M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
VTAK SEC FilingsCatheter Precision 10-K, 10-Q, 8-K Forms - Stock Titan
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. - 富途牛牛
VTAK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stop Loss: Can Catheter Precision Inc stock double in the next yearWeekly Trend Report & Trade Opportunity Analysis - baoquankhu1.vn
Retail Trends: Is Catheter Precision Inc stock undervalued right nowJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
VTAKCatheter Precision Latest Stock News & Market Updates - Stock Titan
Catheter Precision, Inc. Common Stock (NY: VTAK - The Chronicle-Journal
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Benzinga
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth - marketscreener.com
Electrophysiology firm sells catheter line for 5% stake and decade of royalties - Stock Titan
Catheter Precision acquires 20% stake in Creatd’s aviation subsidiary By Investing.com - Investing.com Australia
Royalty swapped for Series J preferred at Catheter Precision (VTAK) - Stock Titan
VTAK Acquires 20% Stake in Creatd’s Aviation Subsidiary Fly Flyte - citybuzz -
Catheter Precision acquires 20% stake in Creatd’s aviation subsidiary - Investing.com
Catheter Buys Stake in Fly Flyte - Baystreet.ca
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. - Benzinga
AI regional air service Fly Flyte gains NYSE investor VTAK - Stock Titan
VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. - The Globe and Mail
VTAK Acquires 20% Interest in Creatd’s Subsidiary Fly Flyte, Inc. - GlobeNewswire
What consensus target says about Catheter Precision Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - mfd.ru
Can Catheter Precision Inc. (4RM0) stock sustain margin levels2025 Performance Recap & Stepwise Trade Signal Implementation - mfd.ru
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Catheter Precision Secures Strategic Financing and Converts Royalties - The Globe and Mail
Catheter Precision, Inc. secures up to $36.5 million in strategic institutional financing to accelerate growth - marketscreener.com
Breakout Watch: Is Catheter Precision Inc forming higher highs and higher lows2025 Major Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth - The Globe and Mail
Catheter Precision, Inc. Secures Up To $36.5 Million In Strategic Institutional Financing To Accelerate Growth - TradingView
Catheter Precision (VTAK) Terminates ATM Equity Offering Program, Secures $36.5 Million Strategic Financing for Growth - Quiver Quantitative
Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to ... - Bluefield Daily Telegraph
Electrophysiology firm Catheter Precision lines up $36.5M for growth - Stock Titan
Earnings Beat: Can Catheter Precision Inc deliver consistent EPS growth2025 Price Action Summary & Real-Time Volume Analysis - baoquankhu1.vn
Is Catheter Precision Inc. (4RM0) stock a contrarian opportunityJuly 2025 News Drivers & Long-Term Growth Plans - mfd.ru
What are Catheter Precision Inc.’s earnings expectationsJuly 2025 Highlights & Short-Term Swing Trade Alerts - mfd.ru
Analyst Downgrade: Is Catheter Precision Inc benefiting from innovation trendsJuly 2025 Earnings & Daily Profit Focused Screening - baoquankhu1.vn
Catheter Precision Restructures Financing and Strategic Investment Plans - The Globe and Mail
Catheter Precision Signs Multiple Material Agreements - TradingView
Catheter Precision, Inc. announced that it expects to receive $5.409429 million in funding - marketscreener.com
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference - The Manila Times
Catheter Precision Announces Accelerated Momentum for Locket Device with New Hospital Approvals - marketscreener.com
Catheter Precision (VTAK) Gains Momentum with LockeT Device Appr - GuruFocus
Catheter Precision Announces Accelerated Momentum for LockeT Device with New Hospital Approvals and Strong Q1 Adoption Outlook - The Manila Times
Same-day discharge wound device lands trials at major US hospitals - Stock Titan
Aug Gainers: Does Catheter Precision Inc have strong EBITDA marginsPortfolio Gains Summary & Weekly Top Stock Performers List - baoquankhu1.vn
Competitive Analysis: Key Market Leaders and New Entrants in the Robotic Catheter Navigation Systems Industry - openPR.com
Comprehensive Report Reviews the Outlook on the Robotic Catheter Navigation Systems Market: Major Growth Tr... - WhaTech
Does Catheter Precision Inc have pricing powerJuly 2025 Final Week & Consistent Return Strategy Ideas - baoquankhu1.vn
Retail Trends: Will Catheter Precision Inc stock benefit from M A2025 Biggest Moves & Daily Profit Maximizing Tips - baoquankhu1.vn
Aug Rallies: Is H2O America a strong growth stockQuarterly Investment Review & Stepwise Trade Execution Plans - baoquankhu1.vn
VTAK Secures First German Purchase Order as LockeT Enters Europe - GuruFocus
Catheter Precision Receives First Purchase Order for LockeT in Germany - Yahoo Finance
Quarterly Risk: Is Catheter Precision Inc benefiting from interest rate changes2025 Stock Rankings & Momentum Based Trading Signals - baoquankhu1.vn
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Cap:
|
Volume (24h):